Medical Equipment

Hemato Oncology Testing Market Expansion to $6.76 Billion by 2029: Key Drivers and Trends

December 4, 2025 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the hemato oncology testing market from 2025–2034 with trusted insights from The Business Research Company

What Is The Base Market Size For The Hemato Oncology Testing Market Today And What Will It Reach By 2029?

The hemato oncology testing market size has witnessed rapid growth in recent years. It is forecast to grow from $3.5 billion in 2024 to $3.93 billion in 2025, with a compound annual growth rate (CAGR) of 12.5%. This historical growth can be attributed to an increasing incidence of cancer, expanding awareness and screening programs, rising healthcare expenditure, the growing adoption of personalized medicine, and an increasing incidence of blood disorders.

The hemato oncology testing market is projected for significant expansion in the coming years. This market is set to reach $6.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 14.5%. Key factors contributing to this anticipated growth include trends in personalized medicine, the incorporation of artificial intelligence, an increasing elderly demographic, progress in genomic research, and the growing need for early cancer diagnosis. Major trends anticipated in the forecast period comprise technological advancements in genomic testing, the adoption of liquid biopsy for non-invasive testing, industry collaborations and partnerships, the evolving regulatory landscape and standardization, and further technological advancements.

Access A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10075&type=smp

What Factors Are Boosting The Hemato Oncology Testing Market?

The rising incidence of hematologic cancer is projected to fuel the expansion of the hemato oncology testing market moving forward. Hematologic cancer refers to a group of malignancies that begin in the blood, affecting the blood, bone marrow, and lymphatic system, and includes diseases such as leukemia, lymphoma, and myeloma. Early diagnosis, achievable through hemato oncology testing, can help reduce the severity of these conditions. For instance, in 2023, the American Cancer Society, a US-based voluntary health organization focusing on eliminating cancer, estimated that leukemia would affect 59,610 Americans and cause 23,710 deaths. Furthermore, new patients of non-Hodgkin lymphoma are expected to impact 80,550 people in the United States and lead to 20,180 deaths. As a result, the increasing prevalence of hematologic cancers is driving the hemato oncology market forward.

How Is The Hemato Oncology Testing Market Categorized By Application, Type, And Region?

The hemato oncology testingmarket covered in this report is segmented –

1) By Product And Services: Assay Kits And Reagents, Services

2) By Cancer Type: Leukemia, Lymphoma, Multiple Myeloma, Other Cancers

3) By Technology: Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), Next-Generation Sequencing (NGS), Other Technologies

4) By End User: Hospitals, Academic And Research Institutes, Other End Users

Subsegments:

1) By Assay Kits And Reagents: PCR Kits, Next-Generation Sequencing (NGS) Kits, Flow Cytometry Reagents, ELISA Kits, Antibodies

2) By Services: Testing Services, Consultation Services, Data Analysis Services

How Are Technological Trends Affecting The Hemato Oncology Testing Market Growth?

Major companies operating in the hemato-oncology testing market are implementing new innovations, such as next-generation sequencing (NGS), to improve the precision and pace of genetic analysis, allow for comprehensive profiling of hematologic malignancies, and support personalized treatment strategies tailored to individual patient needs. Next-generation sequencing (NGS) is a high-throughput DNA sequencing technology that facilitates the rapid and cost-effective examination of entire genomes or targeted DNA regions. For instance, in October 2024, NeoGenomics Inc., a US-based cancer diagnostics and genomic testing company, introduced AML Express, an NGS tool developed for the quick detection of mutations linked to Acute Myeloid Leukemia (AML). This advanced diagnostic platform offers significant accuracy and a swift turnaround, aiding oncologists in making timely, targeted treatment decisions. AML Express aims to enhance patient outcomes by providing precise mutation insights specific to AML’s genetic profiles.

Who Are The Global Leaders Steering The Hemato Oncology Testing Market Forward?

Major companies operating in the hemato oncology testing market include F. Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Illumina Inc., Invivoscribe Inc., Qiagen N.V., Bio-Rad Laboratories Inc., Archerdx Inc., ARUP Laboratories Inc., Asuragen Inc., Adaptive Biotechnologies Corp., Cepheid Inc., EntroGen Inc., CORE Diagnostics Inc., Genoptix Inc., GenPath Diagnostics, NeoGenomics Laboratories Inc., Siemens AG, Sysmex Corporation, Laboratory Corporation of America Holdings, Agilent Technologies, Danaher Corporation, Grifols SA, Diaorin SpA, HTG Molecular Diagnostics Inc., Admera Health

Download The Full Report Here:

https://www.thebusinessresearchcompany.com/report/hemato-oncology-testing-global-market-report

Which Region Is Projected To Achieve The Fastest Growth In The Hemato Oncology Testing Market?

North America was the largest region in the hemato oncology testing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global hemato oncology testing market report during the forecast period. The regions covered in the hemato oncology testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Get A Report Customized For You Here:

https://www.thebusinessresearchcompany.com/customise?id=10075&type=smp

Browse Through More Reports Similar to the Global Hemato Oncology Testing Market 2025, By The Business Research Company

Nutritional Feed Additives Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/nutritional-feed-additives-global-market-report

Wheat Protein Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/wheat-protein-global-market-report

Clinical Nutritions Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/clinical-nutritions-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795